432 related articles for article (PubMed ID: 37492198)
1. Integrated multiple-microarray analysis and mendelian randomization to identify novel targets involved in diabetic nephropathy.
Fan C; Gao Y; Sun Y
Front Endocrinol (Lausanne); 2023; 14():1191768. PubMed ID: 37492198
[TBL] [Abstract][Full Text] [Related]
2. Seven basement membrane-specific expressed genes are considered potential biomarkers for the diagnosis and treatment of diabetic nephropathy.
Gui H; Chen X; Ye L; Ma H
Acta Diabetol; 2023 Apr; 60(4):493-505. PubMed ID: 36627452
[TBL] [Abstract][Full Text] [Related]
3. Integrated Bioinformatics and Clinical Correlation Analysis of Key Genes, Pathways, and Potential Therapeutic Agents Related to Diabetic Nephropathy.
Chen S; Chen L; Jiang H
Dis Markers; 2022; 2022():9204201. PubMed ID: 35637650
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics Analysis of the Mechanisms of Diabetic Nephropathy
Guo M; Dai Y; Jiang L; Gao J
Front Endocrinol (Lausanne); 2022; 13():934022. PubMed ID: 35909518
[TBL] [Abstract][Full Text] [Related]
5. Network pharmacology combined with Mendelian randomization analysis to identify the key targets of renin-angiotensin-aldosterone system inhibitors in the treatment of diabetic nephropathy.
Zhou D; Zhou T; Tang S; Li Q; Li W; Gan G; Li M; Chen Q
Front Endocrinol (Lausanne); 2024; 15():1354950. PubMed ID: 38332893
[TBL] [Abstract][Full Text] [Related]
6. Identification of key genes and biological regulatory mechanisms in diabetic nephropathy: Meta-analysis of gene expression datasets.
Hojjati F; Roointan A; Gholaminejad A; Eshraghi Y; Gheisari Y
Nefrologia (Engl Ed); 2023; 43(5):575-586. PubMed ID: 36681521
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel therapeutic targets for chronic kidney disease and kidney function by integrating multi-omics proteome with transcriptome.
Si S; Liu H; Xu L; Zhan S
Genome Med; 2024 Jun; 16(1):84. PubMed ID: 38898508
[TBL] [Abstract][Full Text] [Related]
8. RNA-Seq Analysis of ceRNA-Related Networks in the Regulatory Metabolic Pathway of Mice with Diabetic Nephropathy Subjected to Empagliflozin Intervention.
Wu T; Zhang Z; Huang H; Wu X
Arch Esp Urol; 2023 Nov; 76(9):680-689. PubMed ID: 38053423
[TBL] [Abstract][Full Text] [Related]
9. Identification of Key Genes of Human Advanced Diabetic Nephropathy Independent of Proteinuria by Transcriptome Analysis.
Cai F; Zhou X; Jia Y; Yao W; Lv J; Liu G; Yang L
Biomed Res Int; 2020; 2020():7283581. PubMed ID: 32685522
[TBL] [Abstract][Full Text] [Related]
10. Identifying C1QB, ITGAM, and ITGB2 as potential diagnostic candidate genes for diabetic nephropathy using bioinformatics analysis.
Hu Y; Yu Y; Dong H; Jiang W
PeerJ; 2023; 11():e15437. PubMed ID: 37250717
[TBL] [Abstract][Full Text] [Related]
11. Causality between sarcopenia and diabetic nephropathy: a bidirectional Mendelian randomization study.
Ren L; Wang Y; Ju F; Sun M; Gang X; Wang G
Front Endocrinol (Lausanne); 2023; 14():1188972. PubMed ID: 37284212
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the Mechanism of Complement System in Diabetic Nephropathy via Bioinformatics Analysis.
Xu B; Wang L; Zhan H; Zhao L; Wang Y; Shen M; Xu K; Li L; Luo X; Zhou S; Tang A; Liu G; Song L; Li Y
J Diabetes Res; 2021; 2021():5546199. PubMed ID: 34124269
[TBL] [Abstract][Full Text] [Related]
13. Identification of transcription factors related to diabetic tubulointerstitial injury.
Liu J; Duan G; Yang W; Zhang S; Liu F; Peng Y; Sun L; Liu Y; Xiao L
J Transl Med; 2023 Mar; 21(1):228. PubMed ID: 36978091
[TBL] [Abstract][Full Text] [Related]
14. Genomic expression profiling and bioinformatics analysis on diabetic nephrology with ginsenoside Rg3.
Wang J; Cui C; Fu L; Xiao Z; Xie N; Liu Y; Yu L; Wang H; Luo B
Mol Med Rep; 2016 Aug; 14(2):1162-72. PubMed ID: 27279428
[TBL] [Abstract][Full Text] [Related]
15. Body Mass Index and Risk of Diabetic Nephropathy: A Mendelian Randomization Study.
Lu J; Liu X; Jiang S; Kan S; An Y; Zheng C; Li X; Liu Z; Xie G
J Clin Endocrinol Metab; 2022 May; 107(6):1599-1608. PubMed ID: 35191949
[TBL] [Abstract][Full Text] [Related]
16. Separating the effects of life course adiposity on diabetic nephropathy: a comprehensive multivariable Mendelian randomization study.
Zhang H; Zhang Q; Song Y; Wang L; Cai M; Bao J; Yu Q
Front Endocrinol (Lausanne); 2024; 15():1285872. PubMed ID: 38390197
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of diabetic nephropathy expression profile based on weighted gene co-expression network analysis algorithm.
Gholaminejad A; Fathalipour M; Roointan A
BMC Nephrol; 2021 Jul; 22(1):245. PubMed ID: 34215202
[TBL] [Abstract][Full Text] [Related]
18. Identification of tubulointerstitial genes and ceRNA networks involved in diabetic nephropathy via integrated bioinformatics approaches.
Cao H; Rao X; Jia J; Yan T; Li D
Hereditas; 2022 Sep; 159(1):36. PubMed ID: 36154667
[TBL] [Abstract][Full Text] [Related]
19. Identification of Hub Genes Involved in Tubulointerstitial Injury in Diabetic Nephropathy by Bioinformatics Analysis and Experiment Verification.
Yang J; Peng L; Tian Y; Tang W; Peng L; Ning J; Li D; Peng Y
J Immunol Res; 2022; 2022():7907708. PubMed ID: 35991124
[TBL] [Abstract][Full Text] [Related]
20. Integrative analyses of biomarkers and pathways for diabetic nephropathy.
Li B; Zhao X; Xie W; Hong Z; Zhang Y
Front Genet; 2023; 14():1128136. PubMed ID: 37113991
[No Abstract] [Full Text] [Related]
[Next] [New Search]
